Effectiveness and tolerability of treatment intensification to basal–bolus therapy in patients with type 2 diabetes on previous basal insulin-supported oral therapy with insulin glargine or supplementary insulin therapy with insulin glulisine: the PARTNER observational study

BACKGROUND: Due to the progressive nature of type 2 diabetes mellitus (T2DM), antidiabetic treatment needs to be continuously intensified to avoid long-term complications. In T2DM patients on either basal insulin-supported oral therapy (BOT) or supplementary insulin therapy (SIT) presenting with HbA...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Vasc Health Risk Manag
Главные авторы: Pfohl, Martin, Siegmund, Thorsten, Pscherer, Stefan, Pegelow, Katrin, Seufert, Jochen
Формат: Artigo
Язык:Inglês
Опубликовано: Dove Medical Press 2015
Предметы:
Original Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4642811/
https://ncbi.nlm.nih.gov/pubmed/26604774
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S82720
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы